0001209191-18-012450.txt : 20180222 0001209191-18-012450.hdr.sgml : 20180222 20180222163600 ACCESSION NUMBER: 0001209191-18-012450 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180220 FILED AS OF DATE: 20180222 DATE AS OF CHANGE: 20180222 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Richard John P CENTRAL INDEX KEY: 0001296528 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-51173 FILM NUMBER: 18633065 MAIL ADDRESS: STREET 1: 260 LITTLEFIELD AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CATALYST BIOSCIENCES, INC. CENTRAL INDEX KEY: 0001124105 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 562020050 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 260 LITTLEFIELD AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 6507450655 MAIL ADDRESS: STREET 1: 260 LITTLEFIELD AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: TARGACEPT INC DATE OF NAME CHANGE: 20000919 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-02-20 0 0001124105 CATALYST BIOSCIENCES, INC. CBIO 0001296528 Richard John P 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080 1 0 0 0 Redeemable Convertible Note 137.85 2018-02-20 4 J 0 16559.00 0.00 D Common Stock 120 0.00 D Reflects a 1:15 reverse stock split effected on February 10, 2017. Reflects a redeemable convertible note of the Issuer (the "Note") that matured, with the face value of the Note repaid to the Reporting Person. At the option of the Reporting Person, at any time on or before February 19, 2018, the Note was redeemable into cash at a rate of $1 for each $1 principal amount of the Note or convertible into shares of common stock of the Issuer at a conversion rate of $137.85 per share, respectively. The Note matured on February 19, 2018. /s/ Faisal Shawwa, Attorney-in-Fact for John P. Richard 2018-02-22